The popularity of Viagra initially sparked a surge for pharma, however recent developments present a complicated outlook for investors. Generic competitors are eroding profits, and continued legal battles add more risk https://zubairhzyg690113.timeblog.net/77064897/sildenafil-and-big-pharma-a-risky-bet